FNY Investment Advisers’s CERo Therapeutics CERO Stock Holding History

FNY Investment Advisers’s Portfolio CERO Stock Details CERO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,050	Closed	-$5K	–	1565
2025 Q3	$5K	Hold	1,050	–	–	﹤0.01%	934
2025 Q2	$10K	Buy	1,050 +1,037	+7,977%	+$12.9K	﹤0.01%	669
2025 Q1	$0	Hold	13	–	–	﹤0.01%	1029
2024 Q4	$157K	Hold	13	–	–	0.08%	219
2024 Q3	$2K	Buy	13 +10	+333%	+$3.05K	﹤0.01%	614
2024 Q2	$1K	Sell	3 -2	-40%	-$4.64K	﹤0.01%	428
2024 Q1	$32	Buy	+5	New	+$55.9K	0.02%	314
2023 Q3	–	Sell	-1	Closed	-$22K	–	777
2023 Q2	$22K	Buy	+1	New	+$21.7K	0.03%	235

FNY Investment Advisers's CERO Position: Q4 2025 in Review

FNY Investment Advisers sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 1,050 shares — an estimated $5K sold.

FNY Investment Advisers first reported a position in CERO in Q2 2023 and held it in 8 quarters. The position peaked at $157K in Q4 2024. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

FNY Investment Advisers reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
FNY Investment Advisers sold 1,050 CERo Therapeutics shares in Q4 2025, an estimated $5K.
FNY Investment Advisers first reported a position in CERo Therapeutics in Q2 2023 and held it in 8 quarters.
FNY Investment Advisers's CERo Therapeutics position peaked at $157K in Q4 2024.
0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.